About the Authors
- Christian Damasco
-
Affiliation Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
- Antonio Lembo
-
Affiliation Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
- Maria Patrizia Somma
-
Affiliation Dipartimento di Biologia e Biotecnologie, and Istituto di Biologia e Patologia Molecolari del CNR, “Sapienza” Università di Roma, Roma, Italy
- Maurizio Gatti
-
Affiliation Dipartimento di Biologia e Biotecnologie, and Istituto di Biologia e Patologia Molecolari del CNR, “Sapienza” Università di Roma, Roma, Italy
- Ferdinando Di Cunto
-
Affiliation Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
- Paolo Provero
-
* E-mail: paolo.provero@unito.it
Affiliation Molecular Biotechnology Center and Department of Genetics, Biology and Biochemistry, University of Turin, Turin, Italy
Competing Interests
The authors declare that they have deposited a patent application covering the commercial use of the DM signature as a prognostic tool for breast cancer.
Author Contributions
Conceived and designed the experiments: MG FDC PP. Performed the experiments: CD. Analyzed the data: CD AL MPS MG FDC PP. Wrote the paper: MG FDC PP.